Kangji Medical Holdings Limited commences an Equity Buyback Plan for 125,220,750 shares, representing 10% of its issued share capital, under the authorization approved on May 26, 2021.
September 29, 2021 at 03:05 pm
Share
Kangji Medical Holdings Limited (SEHK:9997)commences share repurchases on September 29, 2021, under the program mandated by the shareholders in the Annual General Meeting held on May 26, 2021. As per the mandate, the company is authorized to repurchase up to 125,220,750 shares, representing 10% of its issued share capital. The repurchases will lead to an enhancement of the net asset value per share and/or earnings per share for the company. The repurchases will be made out of the funds legally available for such purpose in accordance with its memorandum of association and Bye-laws and the applicable laws and regulations of Cayman Islands. The authority shall expire at the earliest of the next Annual General Meeting, the date on which the next Annual General Meeting is required to be held or the date on which the authority is varied or revoked in a General Meeting. As of May 26, 2021, the company had 1,252,207,500 shares in issue
Kangji Medical Holdings Ltd is a China-based investment holding company mainly engaged in the design, development, manufacture and sale of minimally invasive surgical instruments and accessories. The Company's main products include disposable trocars, polymer ligation clips, disposable electrocoagulation forceps and other disposable products, which are used in gynecology and obstetrics, urology, general surgery and thoracic surgery. The Company distributes its products within the domestic market and to overseas markets.
Kangji Medical Holdings Limited commences an Equity Buyback Plan for 125,220,750 shares, representing 10% of its issued share capital, under the authorization approved on May 26, 2021.